A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

Prostate cancer blood tests ‘can lead to men being over-tested’, experts say - The PSA test measures the amount of a protein made by prostate gland cells and can indicate cancer.

Oura launches blood test through Health Panels. The feature tests 50 biomarkers. Blood testing through wearable tech is the trend du jour. Tech companies want your blood now. That's the latest trend ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

Fitness band maker Whoop formally opened Whoop Advanced Labs for business on Tuesday. Some 350,000 people were on the waitlist after the service was previewed in May, the company told TechCrunch.

A new study from Karolinska Institutet, published in the journal The BMJ, shows how a simple blood analysis can predict the risk of developing severe liver disease. The method may already start to be ...

Guardian’s multiyear distribution agreement with Quest will broaden access to Shield, which is the first blood test to gain Food and Drug Administration approval as a primary screening option for ...

Multi-cancer blood tests, with the promise of detecting many cancer types from a single sample, have the potential to transform cancer screening. However, evidence is lacking to support broad use of ...

Researchers are studying tests called liquid biopsies, which can provide vital information about cancer genes using only a blood sample. A blood test to find cancer even before it shows any symptoms ...

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital, and four other institutions have devised a novel method to test for prostate cancer using biomarkers ...

Exact Sciences has launched its long-awaited blood test designed to detect the early stages of multiple tumors, with a plan to sell it to consumers through a telehealth program in a bid to increase ...